Accessibility Menu
Vireo Growth logo

Vireo Growth

(OTC) VREOF

Current Price$9.78
Market Cap$480.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-93%
5 Year-82%
1 Year-27%
1 Month-13%
Vireo Growth last closing stock price
MetricPriceDate
Last closeUSD 9.762026-07-16
Vireo Growth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.61%USD 9.822026-07-09
1 month-13.44%USD 11.282026-06-16
3 month-20.82%USD 12.332026-04-17
Year to date-46.92%USD 18.392025-12-31
1 year-27.22%USD 13.412025-07-16
3 year+100.21%USD 4.882023-07-17
5 year-81.72%USD 53.402021-07-16
Since inception-92.93%USD 138.012019-03-25

Vireo Growth Financials at a Glance

Market Cap

$480.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$350.43M

Net Income (TTM)

-$81.91M

EPS (TTM)

-$2.78

P/E Ratio

-3.52

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$9.78

Volume

15,532

Open

$9.76

Previous Close

$9.78

Daily Range

$9.60 - $9.84

52-Week Range

$8.91 - $24.00

Estimated Earnings Date

Aug 12, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vireo Growth

Vireo Growth Inc. is a cannabis company engaged in the cultivation, manufacturing, processing, and distribution of medical and adult-use cannabis products across several states in the U.S. The company operates a network of retail dispensaries and distributors, aiming to provide high-quality cannabis products to its customers.

Products and Services
  • Medical and adult-use cannabis products
  • Retail dispensaries in multiple states
  • Distribution through a network of partners
Growth Outlook
  • Revenue increased to $106.2 million in Q1 2026
  • Gross profit margin improved to 55.8% in the latest quarter
  • Expansion into new markets expected to drive future growth
Financial Highlights
  • Net income for Q1 2026 was -$20.0 million
  • Operating income margin reached 16.4% in Q1 2026
  • Cash and cash equivalents totaled $122.4 million as of March 31, 2026
Vireo Growth Inc. has positioned itself as a significant player in the cannabis industry, with a focus on both medical and recreational markets. The company's recent revenue growth reflects its ability to capture market share and respond to consumer demand. The improvement in gross profit margin indicates effective cost management and operational efficiency. Despite reporting a net loss, the substantial cash reserves provide a buffer for ongoing operations and potential expansion initiatives. The strategic focus on entering new markets is expected to enhance revenue streams and solidify the company's presence in the evolving cannabis landscape.
AI Generated • Jun 29, 2026

Industry

Pharmaceuticals

Employees

612

CEO

John Mazarakis, MBA

Headquarters

Minneapolis, MN 55402, US

VREOF Financials

Key Financial Metrics (TTM)

Gross Margin

49.65%

Operating Margin

3.19%

Net Income Margin

-23.37%

Return on Equity

-29.35%

Return on Capital

1.66%

Return on Assets

-8.82%

Earnings Yield

-28.41%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$480.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

49.27M

Volume

15.53K

Avg. Volume

13.11K

Financials (TTM)

Gross Profit

$173.98M

Operating Income

$11.19M

EBITDA

$30.96M

Operating Cash Flow

$18.93M

Capital Expenditure

-$39.47M

Free Cash Flow

-$20.54M

Cash & ST Invst.

$123.40M

Total Debt

$405.03M

Vireo Growth Performance Analysis

Vireo Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 74,625,86737.1%
20232023-12-31USD 88,133,16318.1%
20242024-12-31USD 99,384,22112.8%
20252025-12-31USD 268,769,268170.4%
Vireo Growth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3095.8%
Q32025-09-3090.7%
Q42025-12-3114.0%
Q12026-03-311.6%
Vireo Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -9.9421.8%
20232023-12-31USD -5.67-43.0%
20242024-12-31USD -4.66-17.8%
20252025-12-31USD -2.78-40.3%
Vireo Growth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-50.0%
Q32025-09-308.7%
Q42025-12-3128.1%
Q12026-03-315.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$106.20M

+332.7%

Gross Profit

$59.30M

+377.8%

Gross Margin

55.84%

N/A

Market Cap

$480.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$942.94K

N/A

Employees

510

N/A

Net Income

-$20.30M

-211.9%

EBITDA

$24.06M

+569.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$123.40M

+43.1%

Total Debt

$405.03M

+349.7%

Accounts Receivable

$35.82M

+133.3%

Inventory

$76.10M

+226.0%

Long Term Debt

$381.25M

+328.8%

Short Term Debt

$23.70M

+931.3%

Return on Assets

-8.82%

N/A

Return on Invested Capital

1.57%

N/A

Free Cash Flow

$1.10M

+124.6%

Operating Cash Flow

$11.90M

+458.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INNPFINNOCAN PHARMA Corp
$1.60-8.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
AALAmerican Airlines Group
$14.98-0.04%
INTCIntel
$95.04-0.02%
NOKNokia
$10.12-0.03%

Questions About VREOF

What is the current price of Vireo Growth?

Vireo Growth is trading at $9.78 per share.

What is the 52-week range for Vireo Growth?

Over the past 52 weeks, Vireo Growth has traded between $8.91 and $24.00.

How much debt does Vireo Growth have?

As of the most recent reporting period, Vireo Growth reported total debt of $403.70M.

How much cash does Vireo Growth have on hand?

Vireo Growth reported $137.80M in cash and cash equivalents in its most recent financial results.

What is Vireo Growth’s dividend yield?

Vireo Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.